AB, Dartmouth PhD, California Institute of Technology
Mike Ross is a managing partner at SV Life Sciences, an international venture capital fund focused exclusively in the life sciences Mike has been at SV Life Sciences for 12 years. Prior to joining SV Life Sciences, Michael was the tenth employee at Genentech where he worked for 13 years. He served as Genentech team leader for Humulin® (human insulin-Lilly), Roferon® (Interferon alpha -Roche), Protropin® (hGH), and as Vice President of Development during the development of Activase®, Nutropin® and Pulmozyme®. Michael then started Genentech's protein and antibody engineering and small molecule discovery effort as Vice President of Medicinal and Biomolecular Chemistry. Michael was the Founding CEO of Arris Pharmaceutical (now part of Quest), MetaXen (now part of Exelixis), ExSAR and CyThera (now part of Viacyte).
Michael received his AB in chemistry from Dartmouth, his PhD in chemistry at Caltech, and held an NIH postdoctoral fellowship in Molecular Biology at Harvard.